FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:1632-1635 November 26, 1998 Number 22 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

A variety of congenital cardiovascular abnormalities are the principal causes of sudden death in young competitive athletes,^1,2,3,4,5 and some of these tragedies have been widely publicized.⁶ The identification of important cardiovascular abnormalities in highly trained athletes often leads to medical and legal controversy over the decision to disqualify such athletes from competition.^6,7 The criteria for assessing medical eligibility in such circumstances have been of interest to athletes and their families, their physicians, and representatives of the schools or teams involved, as well as the legal profession.^8,9,10 Sometimes such debates have attracted the attention of the general public and the medical . . . [Full Text of this Article]

Case Report

The University's Decision

The District Court's Decision

The Appellate Court's Decision

Discussion

Address reprint requests to Dr. Maron at the Minneapolis Heart Institute Foundation, 920 E. 28th St., Suite 40, Minneapolis, MN 55407.

References

Related Letters:

Competitive Athletes with Cardiovascular Disease
Chessare J. B., Maron B. J., Mitten M. J., Quandt E. F., Zipes D. P.
Extract | Full Text  
N Engl J Med 1999; 340:1371-1372, Apr 29, 1999. Correspondence

This article has been cited by other articles:

• Myerburg, R. J., Vetter, V. L. (2007). Electrocardiograms Should Be Included in Preparticipation Screening of Athletes. Circulation 116: 2616-2626 [Full Text]  
• Maron, B. J., Thompson, P. D., Ackerman, M. J., Balady, G., Berger, S., Cohen, D., Dimeff, R., Douglas, P. S., Glover, D. W., Hutter, A. M. Jr, Krauss, M. D., Maron, M. S., Mitten, M. J., Roberts, W. O., Puffer, J. C. (2007). Recommendations and Considerations Related to Preparticipation Screening for Cardiovascular Abnormalities in Competitive Athletes: 2007 Update: A Scientific Statement From the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation. Circulation 115: 1643-1655 [Full Text]  
• Maron, B. J., Pelliccia, A. (2006). The Heart of Trained Athletes: Cardiac Remodeling and the Risks of Sports, Including Sudden Death. Circulation 114: 1633-1644 [Full Text]  
• Ho, C. Y., Seidman, C. E. (2006). A Contemporary Approach to Hypertrophic Cardiomyopathy. Circulation 113: e858-e862 [Full Text]  
• Paterick, T. E., Paterick, T. J., Fletcher, G. F., Maron, B. J. (2005). Medical and Legal Issues in the Cardiovascular Evaluation of Competitive Athletes. JAMA 294: 3011-3018 [Abstract] [Full Text]  
• Maron, B. J., Zipes, D. P. (2005). Introduction: Eligibility recommendations for competitive athletes with cardiovascular abnormalities--general considerations. J Am Coll Cardiol 45: 1318-1321 [Full Text]  
• Maron, B. J., Ackerman, M. J., Nishimura, R. A., Pyeritz, R. E., Towbin, J. A., Udelson, J. E. (2005). Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. J Am Coll Cardiol 45: 1340-1345 [Full Text]  
• Mitten, M. J., Maron, B. J., Zipes, D. P. (2005). Task Force 12: Legal aspects of the 36th Bethesda Conference recommendations. J Am Coll Cardiol 45: 1373-1375 [Full Text]  
• Maron, B. J., Chaitman, B. R., Ackerman, M. J., Bayes de Luna, A., Corrado, D., Crosson, J. E., Deal, B. J., Driscoll, D. J., Estes, N.A. M. III, Araujo, C. G. S., Liang, D. H., Mitten, M. J., Myerburg, R. J., Pelliccia, A., Thompson, P. D., Towbin, J. A., Van Camp, S. P., for the Working Groups of the American Heart Assoc, (2004). Recommendations for Physical Activity and Recreational Sports Participation for Young Patients With Genetic Cardiovascular Diseases. Circulation 109: 2807-2816 [Abstract] [Full Text]  
• Maron, B. J. (2003). Sudden Death in Young Athletes. NEJM 349: 1064-1075 [Full Text]  
• Roberts, R., Sigwart, U. (2001). New Concepts in Hypertrophic Cardiomyopathies, Part I. Circulation 104: 2113-2116 [Full Text]  
• Priori, S.G., Aliot, E., Blomstrom-Lundqvist, C., Bossaert, L., Breithardt, G., Brugada, P., Camm, A.J., Cappato, R., Cobbe, S.M., Di Mario, C., Maron, B.J., McKenna, W.J., Pedersen, A.K., Ravens, U., Schwartz, P.J., Trusz-Gluza, M., Vardas, P., Wellens, H.J.J., Zipes, D.P. (2001). Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 22: 1374-1450  
• Pfister, G. C., Puffer, J. C., Maron, B. J. (2000). Preparticipation Cardiovascular Screening for US Collegiate Student-Athletes. JAMA 283: 1597-1599 [Abstract] [Full Text]  
• Chessare, J. B., Maron, B. J., Mitten, M. J., Quandt, E. F., Zipes, D. P. (1999). Competitive Athletes with Cardiovascular Disease. NEJM 340: 1371-1372 [Full Text]